prescription glp-1 medications Infographic How GLP-1 medications are transforming
Description
Osataphan S, Macchi C, Singhal G, Chimene-Weiss J, Sales V, Kozuka C, et al
Introduction Incretin-based therapies have been suggested to increase the risk of pancreatitis [13], but evaluation of the true risk is hampered by the small number of cases included in individual phase II and III clinical trials
Decision tree for use of GLP-1 receptor agonists indicated for weight control in patients with obesity or excess weight with comorbidities
doi:10.3390/ijms20081940 170
Allowing adequate time after meals, particularly breakfast, takes advantage of the gastrocolic reflex
